Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Epistem
Epistem
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Pharmaceutical
David Budd to join Epistem as Chief Executive
He will start his new role by the middle of April
Research & Development
Epistem opens US laboratory in Baltimore
Currently offers histology and immunohistochemistry (IHC) services
Research & Development
UK-Norwegian team to develop living skin equivalent testing model
For testing inflammatory responses
Research & Development
Epistem announces three-year collaboration with GSK
Will apply RND-Amp technology to fibrosis research
Research & Development
Epistem signs three-year research deal with sanofi-aventis
Will provide discovery through to clinical biomarker support to sanofi-aventis oncology programmes
Research & Development
Epistem awarded US$3.5m in NIH biodefence contract
Consortium is developing drugs to treat radiation damage to the gastrointestinal tract
Manufacturing
Veritas becomes exclusive distributor in Japan for Epistem
Will enable Epistem to extend its research services in the region
Subscribe now